We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$389M
AUM Growth
+$19.8M
Cap. Flow
-$14.1M
Cap. Flow %
-3.64%
Top 10 Hldgs %
67.8%
Holding
27
New
3
Increased
15
Reduced
6
Closed
3

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$13.4M
2
STJ
St Jude Medical
STJ
+$7.23M
3
MDVN
MEDIVATION, INC.
MDVN
+$7.18M
4
MCK icon
McKesson
MCK
+$6.1M
5
BAX icon
Baxter International
BAX
+$3.59M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$15.6M
2
JNJ icon
Johnson & Johnson
JNJ
+$11.8M
3
CAH icon
Cardinal Health
CAH
+$9.72M
4
SYK icon
Stryker
SYK
+$9.14M
5
RAD
Rite Aid Corporation
RAD
+$7.77M

Sector Composition

Rank Sector Weight
1 Healthcare 86.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BAX icon
1
Baxter International
BAX
$11.7B
$35.8M 9.19%
937,600
+98,200
+12% +$3.59M
BXLT
2
DELISTED
BAXALTA INC COM STK (DE)
BXLT
$35.8M 9.19%
916,000
+23,800
+3% +$830K
LLY icon
3
Eli Lilly
LLY
$1.05T
$34.2M 8.8%
406,390
+40,443
+11% +$3.36M
JNJ icon
4
Johnson & Johnson
JNJ
$609B
$31.1M 8%
302,930
-117,170
-28% -$11.8M
BSX icon
5
Boston Scientific
BSX
$65.4B
$25.9M 6.65%
1,403,360
-328,540
-19% -$5.89M
BIIB icon
6
Biogen
BIIB
$30.4B
$23.1M 5.93%
75,300
+46,700
+163% +$13.4M
IRWD icon
7
Ironwood Pharmaceuticals
IRWD
$635M
$22.9M 5.88%
2,357,459
+176,987
+8% +$1.71M
RVTY icon
8
Revvity
RVTY
$12.3B
$21.8M 5.6%
406,630
+16,270
+4% +$829K
IART icon
9
Integra LifeSciences
IART
$1.5B
$16.8M 4.31%
494,866
+57,940
+13% +$1.81M
BIO icon
10
Bio-Rad Laboratories Class A
BIO
$8.15B
$16.6M 4.27%
119,830
+4,730
+4% +$656K
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$123B
$14.7M 3.77%
116,633
+9,570
+9% +$1.16M
BMY icon
12
Bristol-Myers Squibb
BMY
$124B
$14.6M 3.76%
212,490
-236,310
-53% -$15.6M
CI icon
13
Cigna
CI
$74.5B
$13.2M 3.38%
90,020
+3,420
+4% +$470K
ACH
14
Accendra Health
ACH
$266M
$12M 3.09%
334,302
+13,550
+4% +$490K
MASI
15
DELISTED
Masimo
MASI
$11.9M 3.07%
287,863
-10,160
-3% -$415K
CAH icon
16
Cardinal Health
CAH
$53.5B
$10.1M 2.6%
113,430
-114,470
-50% -$9.72M
MDVN
17
DELISTED
MEDIVATION, INC.
MDVN
$8.04M 2.07%
+166,353
New +$7.18M
THC icon
18
Tenet Healthcare
THC
$16.8B
$7.82M 2.01%
258,090
-28,310
-10% -$929K
WCG
19
DELISTED
Wellcare Health Plans, Inc.
WCG
$7.81M 2.01%
99,865
+13,320
+15% +$1.1M
STJ
20
DELISTED
St Jude Medical
STJ
$7.08M 1.82%
+114,570
New +$7.23M
MCK icon
21
McKesson
MCK
$98.5B
$6.37M 1.64%
+32,300
New +$6.1M
MNTA
22
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$6.3M 1.62%
424,536
+73,616
+21% +$1.23M
CYH icon
23
Community Health Systems
CYH
$465M
$4.88M 1.25%
222,604
+8,918
+4% +$230K
SPPI
24
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$458K 0.12%
76,000
+1,300
+2% +$7.43K
SYK icon
25
Stryker
SYK
$123B
– –
-97,083
Closed -$9.14M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q4 2015 Portfolio in Review

As of Q4 2015, Sector Gamma AS held 27 positions worth $389M, up 5.4% from $369M the previous quarter. Its ten largest holdings account for 68% of the portfolio.

Sector Gamma AS withdrew a net $14.1M in Q4 2015, closing 3 positions and reducing 6 holdings. Its most notable exit was Stryker, an estimated $9.14M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 87% of assets, down from 87% a quarter earlier.

Against the trend, Sector Gamma AS opened a new position in St Jude Medical worth $7.08M.

  • Sector Gamma AS's largest Q4 2015 buy was St Jude Medical: 114,570 shares worth $7.08M.
  • Sector Gamma AS added most to Biogen in Q4 2015, an estimated $13.4M increase.
  • Sector Gamma AS's biggest Q4 2015 reduction was Bristol-Myers Squibb, cutting an estimated $15.6M.
  • Sector Gamma AS fully exited Stryker in Q4 2015, selling an estimated $9.14M.
  • Sector Gamma AS's ten largest holdings make up 68% of its $389M portfolio in Q4 2015.
  • Sector Gamma AS opened 3 new positions and closed 3 in Q4 2015.
  • Sector Gamma AS's portfolio value rose 5.4% quarter-over-quarter to $389M.

Based on Sector Gamma AS's 13F filing for Q4 2015, filed 12 Feb 2016.